Health & Fitness
Health and Fitness
Health and Fitness
Mon, April 29, 2013
Sun, April 28, 2013
Fri, April 26, 2013
Thu, April 25, 2013
me smooth At-Home elos Professional Hair Removal System Debuts on QVC
me smooth At-Home elos Professional Hair Removal System Debuts on QVC -- NEW YORK, April 25, 2013 /PRNewswire/ --
NEW YORK, April 25, 2013 /PRNewswire/ -- Syneron Beauty Inc., a subsidiary of Syneron Medical Ltd. (NASDAQ: [ ELOS ]), the leading global aesthetic device company, is scheduled to introduce its new me smooth at-home professional hair removal system on QVC®April 26. The device will be packaged with a travel bag and an additional elos cartridge.
"We are thrilled to work with QVC to offer the me smooth hair removal system," states Fabian Tenenbaum , chief executive officer of Syneron Beauty. "QVC's multiplatform presence will allow us to educate the consumer about elos technology."
Perfectly timed with summer preparation, me smooth's QVC introduction will empower consumers to achieve smooth, stubble-free skin without the tedious task of shaving and waxing. A revolutionary solution for fast, easy and painless hair removal, me smooth is an at-home device that uses elos technology to deliver effective removal of unwanted hair for all skin tones.
Powered by patented elos technology, which combines Intense Pulsed Light (IPL) and Radio Frequency (RF) energies, the me smooth professional hair removal system selectively targets hair follicles and delivers heat deep into the dermis to inhibit hair regrowth. The treatments are fast and intuitive, eliminating unwanted hair with speed, ease and effectiveness on all skin tones. Legs can be treated in as little as ten minutes with the easy to use applicator. Simply glide the me smooth over skin and let the flashing elos energy take care of the rest.
ABOUT SYNERON BEAUTY
Syneron Beauty is a pioneer in the design, development and distribution of energy-based consumer aesthetic products. The Company's products are based on clinically proven technologies derived from the professional medical aesthetic device market, enabling patients to achieve professional-like results in an at-home setting. Syneron Beauty currently markets the me™ brand of home-use hair removal systems ([ www.mePower.com ]), the Pearl™ family of teeth whitening products and the Tanda™ family of home-use light therapy products. Syneron Beauty is based in New York and is a wholly owned subsidiary of Syneron Medical Ltd. (NASDAQ: ELOS).
ABOUT SYNERON MEDICAL LTD.
Syneron Medical Ltd. (NASDAQ: [ ELOS ]) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets, services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
Any statements contained in this document regarding future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Further, any statements that are not statements of historical fact (including statements containing "believes," "are confident that, "anticipates," "plans," "expects," "may," "will," "would," and similar expressions) should also be considered to be forward-looking statements. There are a number of factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including the risk that the product launch may take longer than expected, as well as the risks set forth in Syneron Medical Ltd.'s most recent Annual Report on Form 20-F, and the other factors described in the filings that Syneron Medical Ltd. makes with the SEC from time to time. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, Syneron Medical Ltd.'s actual results, performance or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements. In addition, the statements in this document reflect the expectations and beliefs of Syneron Medical Ltd. as of the date of this document. Syneron Medical Ltd. anticipates that subsequent events and developments will cause its expectations and beliefs to change. However, while Syneron Medical Ltd. may elect to update these forward-looking statements publicly in the future, it specifically disclaims any obligation to do so. The forward-looking statements of Syneron Medical Ltd. do not reflect the potential impact of any future dispositions or strategic transactions that may be undertaken. These forward-looking statements should not be relied upon as representing Syneron Medical Ltd.'s views as of any date after the date of this document.
SOURCE Syneron Beauty Inc.
